Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:IEX
NYSE:IEXMachinery

Has The Recent Pullback In IDEX (IEX) Opened A Valuation Opportunity For Investors

If you are wondering whether IDEX at around US$186.55 is offering fair value or a potential mispricing, you are not alone. The stock has returned 1.3% over the last 7 days, 4.2% year to date and 4.7% over the past year, but this sits alongside a 9.5% decline over the last 30 days and negative 3 and 5 year returns. These mixed returns have kept attention on IDEX, with investors weighing up how its business profile and industry position compare with current expectations. Recent coverage has...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Is It Time To Reassess Distribution Solutions Group (DSGR) After The US$29.50 Go Private Proposal

How Distribution Solutions Group's recent share price sets up a valuation check Before getting into detailed valuation work, it helps to understand how Distribution Solutions Group's share price has been behaving and what recent information is shaping expectations. Over the last week, the stock has been relatively steady with a 0.2% decline, but the past month has seen a sharper 12.6% pullback and the year to date return sits at a 7.2% loss, with the last 12 months at a 6.8% loss, even though...
NasdaqGS:LGN
NasdaqGS:LGNConstruction

Legence (LGN) Q3 Revenue Strength Tests Bullish Narratives On Path To Profitability

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...
NYSE:DLB
NYSE:DLBSoftware

Is Dolby Laboratories (DLB) Offering Value After Recent Share Price Pullback

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...
NasdaqGM:ZNTL
NasdaqGM:ZNTLBiotechs

Zentalis Pharmaceuticals (ZNTL) Posts Zero Revenue Challenging Bullish Revenue Recovery Narratives

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...
TSE:1605
TSE:1605Oil and Gas

Will Beetaloo Basin Gas JV With Formentera Partners Change Inpex's (TSE:1605) Narrative

Earlier this week, Formentera Partners and INPEX announced a joint venture to accelerate development of onshore natural gas resources in Australia’s Beetaloo Basin, with INPEX gaining acreage through a staged earn-in to support domestic supply and potential LNG exports. This partnership combines Formentera’s shale development capabilities with INPEX’s LNG project experience, potentially creating a new, scalable gas hub that could influence the company’s long-term resource mix and...
NYSE:JBS
NYSE:JBSFood

JBS Index Removal Puts Focus On Valuation Momentum And Dividend Risks

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Is Arch Capital Group (ACGL) Still Attractive After Recent Share Price Softness?

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...
ENXTBR:SOF
ENXTBR:SOFDiversified Financial

Sofina Société Anonyme (ENXTBR:SOF) Swings To €393.9 Million Loss Challenging Margin Resilience Narrative

Sofina Société Anonyme (ENXTBR:SOF) opened FY 2025 with a weak first half, reporting a loss as basic EPS swung to €11.87 and total revenue came in at a loss of €358.9 million. This comes against a backdrop where the trailing twelve months still show positive EPS of €12.48 and revenue of €486.1 million. Over the past year, the company has seen total revenue move from €587.1 million in 2024 H1 to €844.98 million in 2024 H2 and EPS shift from €16.59 to €24.29 in the same periods, before the...
SEHK:1099
SEHK:1099Healthcare

A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement

Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM. See our latest analysis for Sinopharm Group. The proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome. If...
TSX:FOM
TSX:FOMMetals and Mining

A Look At Foran Mining’s Valuation As McIlvenna Bay Construction Nears Completion And Transmission Line Comes Online

Foran Mining (TSX:FOM) has updated investors on construction at its McIlvenna Bay project, reporting progress of about 91% and confirming the site remains on schedule and within budget as commissioning continues. See our latest analysis for Foran Mining. At a share price of CA$5.34, Foran Mining has seen a 2.69% 1 day share price return and a 5.74% 7 day share price return. However, the 30 day share price return shows a 23.71% decline, which contrasts with a 43.55% 1 year total shareholder...
ENXTPA:DBV
ENXTPA:DBVBiotechs

DBV Technologies (ENXTPA:DBV) Quarterly Loss Of US$33.2m Reinforces Bearish Profitability Narratives

DBV Technologies (ENXTPA:DBV) has put fresh numbers on the table for FY 2025, with third quarter revenue of US$2.8 million and a basic EPS loss of US$0.24 alongside a net income loss of US$33.2 million. Together, these figures provide a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue of US$0.5 million in Q4 2024, US$0.8 million in Q1 2025, US$1.5 million in Q2 2025 and US$2.8 million in Q3 2025. Over the same period, quarterly EPS has...
ENXTAM:AGN
ENXTAM:AGNInsurance

Aegon (ENXTAM:AGN) Earnings Margin Surge Challenges Cautious Long Term Profitability Narratives

Aegon (ENXTAM:AGN) has just released its FY 2025 numbers, reporting second half revenue of €2.9 billion, basic EPS of €0.24 and net income of €362 million, set against trailing twelve month EPS of €0.59 and net income of €927 million. The company has seen revenue move from €6.4 billion and EPS of €0.44 in the second half of 2024 to €6.7 billion and EPS of €0.36 in the first half of 2025. Over the same period, trailing twelve month revenue has shifted from €12.8 billion with EPS of €0.37 to...
TASE:RANI
TASE:RANIReal Estate

Rani Zim Shopping Centers (TASE:RANI) Margin Compression Reinforces Bearish Earnings Narratives

Rani Zim Shopping Centers (TASE:RANI) has released its FY 2025 figures, with the latest quarter showing revenue of ₪43.8m and net income of ₪9.1m, equal to EPS of ₪0.05. The trailing 12 months reflect a net profit margin of 15.4% compared with 47.3% a year earlier. Over recent quarters the company has seen revenue move from ₪66.8m in Q3 2024 to ₪56.3m in Q1 2025, then to ₪101.0m in Q2 2025 and ₪43.8m in Q3 2025. EPS shifted from ₪0.59 to a loss of ₪0.06, then ₪0.16 and ₪0.05, as a one-off...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Verra Mobility’s Sales Growth Meets Profitability Strains And Cooling Sentiment

Verra Mobility, NasdaqCM:VRRM, is reporting long term sales growth alongside pressure on free cash flow margins. Recent quarterly results show weaker profitability, prompting questions about investment needs and cost control. Investor sentiment has cooled, with the share price at $13.88 and a 37.8% decline year to date. For shareholders, the story around Verra Mobility is no longer just about sales momentum. The stock is down 37.8% year to date and 31.3% over the past year, with the current...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods (SFD) Is Up 15.4% After Record Profit And Nathan’s Famous Deal - What's Changed

In March 2026, Smithfield Foods reported higher fourth-quarter and full-year 2025 results, issued 2026 guidance for low-single-digit sales growth, announced a quarterly dividend of US$0.3125 per share, and outlined an agreement to acquire the Nathan's Famous packaged meats brand while continuing to evaluate additional M&A opportunities. A key takeaway for investors is Smithfield Foods’ record 2025 operating profit of US$1.30 billion and margin expansion to 8.6%, highlighting improved...
NasdaqGS:SPRO
NasdaqGS:SPROBiotechs

Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives

Spero Therapeutics (SPRO) closed FY 2025 with fourth quarter revenue of US$41.3 million and basic EPS of US$0.56, alongside trailing twelve month revenue of US$66.8 million and EPS of roughly US$0.15 that mark a shift into profitability over the period. Over recent quarters, the company has seen revenue range from US$5.4 million to US$41.3 million with quarterly EPS moving from a loss of about US$0.25 per share at the start of FY 2025 to a profit in the latest quarter, providing a clearer...
NYSE:BTGO
NYSE:BTGOCapital Markets

Bitgo Holdings (BTGO) Revenue Surge Tests Thin 0.5% Margin Narrative

Bitgo Holdings FY 2025 Earnings Snapshot Bitgo Holdings (BTGO) just posted its FY 2025 results with third quarter revenue of about US$5.8 billion, Basic EPS of US$0.19 and net income of US$6.8 million. Trailing twelve month revenue stood at roughly US$11.1 billion with Basic EPS of US$1.49 and net income of US$57.1 million. The company has seen quarterly revenue move from US$817.8 million in FY 2024 Q3 to US$5.8 billion in FY 2025 Q3, and Basic EPS shift from US$0.11 in FY 2024 Q1 and Q2 to...
NasdaqGS:STRS
NasdaqGS:STRSReal Estate

Stratus Properties (STRS) Q3 Loss Deepens And Reinforces Bearish Profitability Narrative

Stratus Properties (STRS) has just posted another tough quarter, with Q3 FY 2025 revenue of US$5.0 million and a basic EPS loss of US$0.62, alongside a net income loss of US$5.0 million. The trailing twelve month picture shows total revenue of US$31.9 million and a net income loss of US$8.1 million. Over recent periods the company has seen quarterly revenue move between US$4.9 million and US$11.6 million, with basic EPS ranging from a small profit of US$0.03 per share to losses of up to...
NasdaqCM:CV
NasdaqCM:CVMedical Equipment

CapsoVision (CV) Q4 Loss Of US$0.16 EPS Tests Bullish Profitability Narratives

CapsoVision (CV) closed FY 2025 with fourth quarter revenue of US$3.9 million, a basic EPS loss of US$0.16 per share, and trailing twelve month revenue of US$13.6 million alongside a trailing EPS loss of US$1.03 per share. Over recent quarters, revenue has moved from US$3.5 million in Q3 2025 and US$3.3 million in Q2 2025 to the latest US$3.9 million print. Basic EPS losses shifted from US$0.17 and US$2.02 over those same periods to US$0.16, leaving investors focused on how quickly margins...
NYSE:CCL
NYSE:CCLHospitality

Carnival Corporation (CCL) 10.4% Net Margin Strengthens Bullish Earnings Narrative

Carnival Corporation (CCL) has kicked off Q1 2026 following a solid run through 2025, with Q4 2025 revenue of US$6.3 billion, basic EPS of US$0.32 and net income of US$422 million framing the latest set of numbers. Over the past few quarters, revenue has moved from US$5.9 billion in Q4 2024 to US$6.3 billion in Q2 2025 and again US$6.3 billion in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.06 in Q1 2025 to US$1.41 in Q3 2025. This has set up a story where rising trailing...
NasdaqCM:SKYX
NasdaqCM:SKYXElectrical

SKYX Platforms (SKYX) Q4 Loss Narrows To US$0.07 EPS And Tests Bearish Profitability Views

SKYX Platforms (SKYX) closed out FY 2025 with Q4 revenue of about US$24.9 million, a basic EPS loss of US$0.07, and a net income loss of roughly US$8.2 million, while the trailing twelve months showed revenue of about US$92.0 million against a net loss of around US$34.5 million and basic EPS of US$0.32 in losses. Over recent quarters the company has seen revenue move from roughly US$23.7 million in Q4 2024 to US$24.9 million in Q4 2025. Quarterly basic EPS losses shifted from about US$0.11 to...
NasdaqGS:VFS
NasdaqGS:VFSAuto

Is It Time To Reassess VinFast Auto (VFS) After Recent Share Price Rebound?

If you are wondering whether VinFast Auto's current share price really reflects what the business is worth, you are not alone. That is exactly what this valuation focused review will tackle. The stock recently closed at US$3.39, with returns of 18.5% over 7 days, 2.7% over 30 days, 0.3% year to date and 0.0% over the last year, alongside a 67.0% decline over 3 years. Recent headlines around VinFast Auto have continued to keep the company on investors' radar and have added fresh context to...